| __timestamp | ADMA Biologics, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 38783000000 |
| Thursday, January 1, 2015 | 6745968 | 42585000000 |
| Friday, January 1, 2016 | 8494742 | 45702000000 |
| Sunday, January 1, 2017 | 18092835 | 46372000000 |
| Monday, January 1, 2018 | 22502922 | 46910000000 |
| Tuesday, January 1, 2019 | 25910757 | 48890000000 |
| Wednesday, January 1, 2020 | 35050817 | 50129000000 |
| Friday, January 1, 2021 | 42896889 | 54559000000 |
| Saturday, January 1, 2022 | 52458024 | 62081000000 |
| Sunday, January 1, 2023 | 59020000 | 105931000000 |
| Monday, January 1, 2024 | 77201000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, understanding the financial strategies of key players is crucial. Dr. Reddy's Laboratories Limited and ADMA Biologics, Inc. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, Dr. Reddy's Laboratories saw a steady increase in SG&A expenses, peaking in 2023 with a staggering 173% rise from 2014. This reflects their aggressive expansion and market penetration strategies. In contrast, ADMA Biologics, Inc. experienced a more modest growth, with expenses increasing by approximately 1,124% over the same period, indicating a significant scaling of operations.
While 2024 data for ADMA Biologics is unavailable, Dr. Reddy's shows a slight decline, suggesting a potential shift in strategy. These trends highlight the dynamic nature of the pharmaceutical industry and the diverse approaches companies take to maintain competitiveness.
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Dr. Reddy's Laboratories Limited vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Exelixis, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited